Dataset
Gemfibrozil; LC-ESI-QTOF; MS2; CE: 30 eV; R=35000; [M+H]+
Chemical Information
| InChI | InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17) |
|---|---|
| SMILES | CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1 |
| InChI Key | HEMJJKBWTPKOJG-UHFFFAOYSA-N |
| Molecular Formula | C15H22O3 |
| Exact Mass | 250.157 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU269103 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2019-05-30 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| 12013353 | PubChem: Drugs of the Future |
| DB01241 | DrugBank |
| CHEMBL457 | ChEMBL |
| 5296 | ChEBI |
| SAM002564211 | NIH Clinical Collection |
| C07020 | KEGG Ligand |
| 50110590 | BindingDB |
| LOPID | rxnorm |
| GEMFIBROZIL | rxnorm |
| CI-719 | clinicaltrials |
| LOPID | clinicaltrials |
| GEMFIBROZIL | clinicaltrials |
| HY-B0258 | MedChemExpress |
| 4TX | PDBe |
| DTXSID0020652 | EPA CompTox Dashboard |
| 1285 | DrugCentral |
| ZINC000001530641 | ZINC |
| 3439 | Guide to Pharmacology |
| J40.721F | Nikkaji |
| XAPVOA | CCDC |
| GEMFIBROZIL | DailyMed |
| 3463 | PubChem |
| PD002321 | ProbesDrugs |
| gemfibrozil | Atlas |
| Q8X02027X3 | FDA SRS |
| 14798621 | PubChem: Thomson Pharma |
| LSM-2227 | LINCS |
| 25812-30-0 | ACToR |
| Gemfibrozil(Lopid) | Selleck |
| SCHEMBL4813 | SureChEMBL |
| 538915 | eMolecules |
| MCULE-4563546953 | Mcule |
| PA449750 | PharmGKB |
| gemfibrozil | DailyMed |
| 6087 | Brenda |
| CB9154247 | ChemicalBook |
| HMDB0015371 | Human Metabolome Database |
| The data in this table is sourced from UniChem at EBI. | |